112 related articles for article (PubMed ID: 8572862)
21. Multislice CT coronary angiography: effect of sublingual nitroglycerine on the diameter of coronary arteries.
Dewey M; Hoffmann H; Hamm B
Rofo; 2006 Jun; 178(6):600-4. PubMed ID: 16703495
[TBL] [Abstract][Full Text] [Related]
22. Intracoronary papaverine induced myocardial lactate production in patients with angiographically normal coronary arteries.
Takeuchi M; Nohtomi Y; Kuroiwa A
Cathet Cardiovasc Diagn; 1996 Oct; 39(2):126-30. PubMed ID: 8922310
[TBL] [Abstract][Full Text] [Related]
23. Assessment of sublingual isosorbide dinitrate and intracoronary nifedipine during ergonovine provocation.
Bethge HD; Bachmann K
Z Kardiol; 1983; 72 Suppl 3():92-7. PubMed ID: 6666236
[TBL] [Abstract][Full Text] [Related]
24. Coronary vasodilation by nitrates is not mediated by the prostaglandin system: an angiographic and hemodynamic study.
Simonetti I; de Caterina R; Marzilli M; de Nes M; L'Abbate A
Z Kardiol; 1983; 72 Suppl 3():40-5. PubMed ID: 6666232
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients.
Antony I; Lerebours G; Nitenberg A
Circulation; 1996 Dec; 94(12):3115-22. PubMed ID: 8989118
[TBL] [Abstract][Full Text] [Related]
26. [Dysfunction of the coronary microcirculation in type 2 diabetic patients].
Nitenberg A; Ledoux S; Valensi P; Sachs R; Attali JR; Antony I
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):937-41. PubMed ID: 10989733
[TBL] [Abstract][Full Text] [Related]
27. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both.
Moliterno DJ; Willard JE; Lange RA; Negus BH; Boehrer JD; Glamann DB; Landau C; Rossen JD; Winniford MD; Hillis LD
N Engl J Med; 1994 Feb; 330(7):454-9. PubMed ID: 8289850
[TBL] [Abstract][Full Text] [Related]
28. [Response of coronary arteries to intracoronary acetylcholine infusion in patients with familial hypercholesterolemia].
Shimizu K; Shimizu M; Sugihara N; Kita Y; Yoshio H; Yamazaki T; Okeie K; Koizumi J; Mabuchi H; Takeda R
J Cardiol; 1992; 22(2-3):439-46. PubMed ID: 1339802
[TBL] [Abstract][Full Text] [Related]
29. Reduced coronary vasodilation in patients with familial hypercholesterolemia following intracoronary injection of isosorbide dinitrate.
Saku K; Jimi S; Sasaki N; Nii T; Shirai K; Koga N; Arakawa K
Jpn Circ J; 1995 Dec; 59(12):808-14. PubMed ID: 8788372
[TBL] [Abstract][Full Text] [Related]
30. Coronary circulation in patients with and without coronary artery disease and the effects of chewable isosorbide dinitrate.
Gensini GG
G Ital Cardiol; 1975; 5(5):714-23. PubMed ID: 1205044
[TBL] [Abstract][Full Text] [Related]
31. Restoration of flow-dependent coronary dilation by ACE inhibition improves papaverine-induced maximal coronary blood flow in hypertensive patients: demonstration that large epicardial coronary arteries are more than conductance vessels.
Antony I; Chemla D; Lerebours G; Nitenberg A
J Cardiovasc Pharmacol; 2000 Nov; 36(5):570-6. PubMed ID: 11065216
[TBL] [Abstract][Full Text] [Related]
32. Plasma concentrations and coronary vasodilation after sublingual and intracoronary administration of isosorbide dinitrate.
Hoshio A; Shirota K; Sasaki N; Doi T; Sawada Y; Fukuki M; Miyakoda H; Kotake H; Mashiba H
Clin Cardiol; 1995 Nov; 18(11):641-6. PubMed ID: 8590533
[TBL] [Abstract][Full Text] [Related]
33. Coronary flow reserve in angiographically normal coronary arteries with one-vessel coronary artery disease without traditional risk factors.
Fujiwara M; Tamura T; Yoshida K; Nakagawa K; Nakao M; Yamanouchi M; Shikama N; Himi T; Masuda Y
Eur Heart J; 2001 Mar; 22(6):479-87. PubMed ID: 11237543
[TBL] [Abstract][Full Text] [Related]
34. Drug plasma levels and coronary vasodilation after isosorbide dinitrate chewing capsules.
Jost S; Rafflenbeul W; Knop I; Bossaller C; Gulba D; Hecker H; Lippolt P; Lichtlen PR
Eur Heart J; 1989 Nov; 10 Suppl F():137-41. PubMed ID: 2620680
[TBL] [Abstract][Full Text] [Related]
35. L-arginine preferentially dilates stenotic segments of coronary arteries thereby increasing coronary flow.
Lauer T; Kleinbongard P; Rath J; Schulz R; Kelm M; Rassaf T
J Intern Med; 2008 Sep; 264(3):237-44. PubMed ID: 18341529
[TBL] [Abstract][Full Text] [Related]
36. [Clinical pathophysiological studies on coronary circulation. 3. The effects of so-called coronary vasodilator agents on coronary circulation in various diseases].
Osugi S
Jpn Circ J; 1971 Feb; 35(2):268-80. PubMed ID: 5109720
[No Abstract] [Full Text] [Related]
37. Coronary vasodilator capacity and epicardial vessel remodeling in physiological and hypertensive hypertrophy.
Kozàkovà M; Galetta F; Gregorini L; Bigalli G; Franzoni F; Giusti C; Palombo C
Hypertension; 2000 Sep; 36(3):343-9. PubMed ID: 10988262
[TBL] [Abstract][Full Text] [Related]
38. Coronary flow velocity dynamics in normal and diseased arteries.
Ofili EO; Labovitz AJ; Kern MJ
Am J Cardiol; 1993 May; 71(14):3D-9D. PubMed ID: 8488773
[TBL] [Abstract][Full Text] [Related]
39. Response of angiographically normal and atherosclerotic left anterior descending coronary arteries to acetylcholine.
Newman CM; Maseri A; Hackett DR; el-Tamimi HM; Davies GJ
Am J Cardiol; 1990 Nov; 66(15):1070-6. PubMed ID: 2220634
[TBL] [Abstract][Full Text] [Related]
40. Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors.
Nitenberg A; Paycha F; Ledoux S; Sachs R; Attali JR; Valensi P
Circulation; 1998 Mar; 97(8):736-43. PubMed ID: 9498536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
